Metabolism of Omega-3 and Omega-6 During Healthy Aging
NCT02957188 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13
Last updated 2016-11-07
Summary
The purpose of this study is to determine the kinetics of 13C-eicosapentaenoic acid (EPA) and 13C-arachidonic acid (AA) in young and older participants
Conditions
- Healthy Volunteers
Interventions
- OTHER
-
13C eicosapentaenoic acid and 13C arachidonic acid
Each participant orally consumed a single oral dose of 35 mg of 13C-EPA, and after the wash-out, a 50 mg dose of 13C-AA.
Sponsors & Collaborators
-
Healthy Aging Research Network
collaborator NETWORK -
Université de Sherbrooke
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-08-31
- Primary Completion
- 2016-07-31
- Completion
- 2016-08-31
More Related Trials
-
Erythrocyte Omega-3 Fatty Acid Content in Elite Athletes
NCT02610270 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparison of EPA and DHA-Rich Fish Oils on Lipoprotein Metabolism In Adults
NCT02514070 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Omega-3 Fatty Acids in Ambient Air Pollution Exposure in Healthy Adults
NCT02921048 ·Status: COMPLETED
-
Impact of EPA and DHA Supplementation on Plasma Biomarkers of Inflammation (n3)
NCT01810003 ·Status: COMPLETED ·Phase: NA
-
Do Apolipoprotein E Polymorphisms Influence Risk of Cognitive Decline by Modulating Omega-3 Fatty Acid Metabolism?
NCT01577004 ·Status: COMPLETED ·Phase: NA
-
The Effect of Omega-3 Supplementation on Muscle Functioning, Inflammation and Muscle Signaling
NCT03986307 ·Status: COMPLETED ·Phase: NA
-
Plasma Diurnal Variation in and Absorption of EPA and DHA
NCT02661698 ·Status: COMPLETED ·Phase: NA
-
Effect of Omega-3 Fatty Acid on Endothelial Function
NCT01813006 ·Status: COMPLETED ·Phase: PHASE3
-
Omega-3 Supplementation and Resistance Training
NCT02617511 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Omega-3 Monoglycerides
NCT04382027 ·Status: COMPLETED ·Phase: NA
-
Impact of 2.0g Daily of MAG-EPA on the AA/EPA Ratio and Inflammation Biomarkers in a Healthy Population Aged of 50+.
NCT04897893 ·Status: COMPLETED ·Phase: PHASE4
-
Transcriptomics of Mononuclear Cells and Inflammatory Status of Obese Patients Treated With Omega-3 Fatty Acids
NCT05219890 ·Status: WITHDRAWN ·Phase: NA
-
Observing Metabolism of EPA With Consideration of Genetics And Sex
NCT06975241 ·Status: RECRUITING ·Phase: PHASE4
-
Intake of Omega 3 in Morbidly Obese Patients
NCT02113696 ·Status: COMPLETED ·Phase: NA
-
Does Incorporation of EPA and DHA in Lipoproteins Differ According to Apolipoprotein E Genotype?
NCT01544855 ·Status: COMPLETED ·Phase: NA
-
Investigating the Effect of 4-week Omega-3 Polyunsaturated Fatty Acid Supplementation on Inflammation
NCT03210805 ·Status: UNKNOWN ·Phase: NA
-
Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)
NCT01056133 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and Inflammation
NCT01310270 ·Status: COMPLETED ·Phase: NA
-
Gender Effects of Dietary Omega-3 Fatty Acids From Plant and Marine Sources on Oxylipins in Healthy Humans
NCT02317588 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of 12 Weeks of Omega 3 Supplementation on Resting Metabolic Rate
NCT02092649 ·Status: COMPLETED ·Phase: NA
-
Effects of N-3 Polyunsaturated Fatty Acids On Chylomicron Secretion And Expression Of Genes That Regulate Intestinal Lipid Metabolism In Men With Type 2 Diabetes
NCT01449773 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Nutritional Status of Omega-3 Fatty Acids and the Possible Influences of Dietary Patterns and Different Socioeconomic Factors, in a Spanish Population Over 60 Years of Age
NCT06916455 ·Status: RECRUITING
-
Efficacy of a Dietary Ingredient Combination With Omega-3 for Joint Function
NCT05279573 ·Status: COMPLETED ·Phase: NA
-
Vascular Impact of Omega-3 in Metabolic Syndrome
NCT01566188 ·Status: COMPLETED ·Phase: NA
-
Effect of Dose of Buglossoides Oil on EPA Accrual and on the Inflammatory Response
NCT02540759 ·Status: COMPLETED ·Phase: PHASE1